KRAS and cancer: In contrast, Abdel‐Hafiz constructed a mouse colorectal cancer (CRC) model, and his research team found that cancer metastasis was higher and the prognosis was worse in male CRC mice carrying the oncogenic KRAS mutation (KRAS*) than that in females (Figure 1B).